Life Science News

RSS

Asynt’s ReactoMate system installed at Imperial College London for chemical engineering research

Asynt has supplied and installed a ReactoMate laboratory reactor system within the Department of Chemical Engineering at Imperial College London. Comprising of bespoke glass reactor vessel, ReactoMate Datum support stand, and DrySyn heating block system, the reactor setup will help further research into the fluid dynamics of fine particulate materials.

From Asynt 1 Mar 2018

Pesticides are accumulated in bodies with high fat content, FEFU scientists say

Pesticides are accumulated in bodies with high fat content. This conclusion was made by the scientists from the Far Eastern Federal University that have been studying seabirds and marine mammals of the Sea of Okhotsk and the Bering Sea for several years.

1 Mar 2018

New study provides better understanding of asymmetric cell division

Stem cells are the basic material from which mature, specialised cells such as muscle and blood cells are produced -- this process is known as differentiation.

28 Feb 2018

Unique progenitor cells in the pancreas have potential to develop glucose-responsive beta cells

Scientists from the Diabetes Research Institute at the University of Miami Miller School of Medicine have confirmed the existence of progenitor cells within the human pancreas that can be stimulated to develop into glucose-responsive beta cells.

28 Feb 2018

UNIGE researchers discover why premature cell division promotes tumor formation

The accumulation of mutations in the human genome is at the origin of cancers, as well as the development of resistance to treatments. The Cyclin E and Myc genes are active in the control of cell division.

28 Feb 2018

RNA-based method cures lung tumors in mice

By turning down the activity of a specific RNA molecule researchers at Sahlgrenska Academy, Sweden, have cured lung tumors in mice by 40-50 percent.

28 Feb 2018

Researchers devise novel approach to develop antibacterial drugs

Researchers at VIB, KU Leuven and UZ Leuven devised a novel approach to develop antibacterial drugs. With antibiotic resistance on the rise worldwide, such new drugs are urgently needed. The Flemish biotech spin-off Aelin Therapeutics will exploit the technology to produce new antibiotics for the clinic.

28 Feb 2018

Tradeshow Talks with Labconco

We talked to product manager Kelly from Labconco at Pittcon 2018.

From Labconco 28 Feb 2018

Pancreatic progenitor cells could be used to treat diabetes, suggests study

Researchers have confirmed the existence of progenitor cells in the pancreas that can be stimulated to turn into glucose-responsive beta cells.

28 Feb 2018

CRISPR-like gene editing could be potential way to treat patients with harmful blood lipid levels

Using a variation of CRISPR gene editing may be a potential strategy for mimicking the protective effects of a genetic mutation linked to lower cholesterol levels and heart disease risks, according to new mouse research from the Perelman School of Medicine at the University of Pennsylvania published this week in Circulation.

28 Feb 2018

Study unravels biological mystery behind 'magical' properties of psychedelic mushrooms

Psychedelic mushrooms likely developed their "magical" properties to trip up fungi-munching insects, suggests new research.

28 Feb 2018

Researchers discover 50 new gene regions that increase risk of schizophrenia

Researchers at the MRC Centre for Neuropsychiatric Genetics and Genomics at Cardiff University have discovered 50 new gene regions that increase the risk of developing schizophrenia.

28 Feb 2018

Quiescent cells also acquire particular type of mutation, research shows

For almost a hundred years, geneticists have believed that the more a cell divides the more mutations it acquires. However, research by scientists at the Institut Pasteur shows that quiescent cells, which do not divide, also acquire a particular type of mutation - deletions (mutations through loss of nucleobases).

27 Feb 2018

Telomere length testing can alter treatment decisions for certain diseases

Research led by Johns Hopkins physicians and scientists shows that a test for measuring the length of DNA endcaps, called telomeres, which has a variability rate of 5 percent, can alter treatment decisions for patients with certain types of bone marrow failure.

27 Feb 2018

New study lays foundation to obtain apple cubes enriched with probiotics

Researchers of the Universitat Politècnica de València and the Universidade Federal do Ceará (Brazil) have completed a study that lays the foundation to obtain apple cubes enriched with probiotics, namely Lactobacillus casei. The work has been published in the most recent edition of the Journal of Functional Foods.

27 Feb 2018

ASU researchers uncover crucial step in telomerase enzyme catalytic cycle

Can we stay young forever, or even recapture lost youth? Research from the laboratory of Professor Julian Chen in the School of Molecular Sciences at Arizona State University recently uncovered a crucial step in the telomerase enzyme catalytic cycle.

27 Feb 2018

Artificial intelligence methods used for developing precision cancer medicine

A patient's own molecular data can be used to identify, with the use of artificial intelligence methods, the best combinatorial multi-drug therapy for that patient. Network modelling plays a major role in this line of work.

27 Feb 2018

Researchers develop new tool that provides 3D view of metabolic processes

An international team of researchers has developed a computational resource that provides a 3D view of genes, proteins and metabolites involved in human metabolism.

27 Feb 2018

UGR study shows potential of cereal-based bread that curbs appetite

UGR researchers, in collaboration with the company Puratos, have conducted an in-depth study on the potential benefits of a cereal-based bread enriched with soluble fiber, proteins and dried fruit. The bread, which curbs the appetite more than traditional breads, is designed to reduce food consumption between meals and thereby control energy intake.

27 Feb 2018

Phasefocus™ appoints Australian distributor as part of expansion

The appointment of ATA Scientific Instruments as the official distributor for Phasefocus™ in Australia and New Zealand marks the latest step in the Imaging and microscopy businesses global expansion plan.

From Phase Focus Limited 26 Feb 2018